Copyright
©2013 Baishideng Publishing Group Co.
World J Gastroenterol. May 14, 2013; 19(18): 2740-2751
Published online May 14, 2013. doi: 10.3748/wjg.v19.i18.2740
Published online May 14, 2013. doi: 10.3748/wjg.v19.i18.2740
Retesting panel1 | First line panel | Second and third line panels | |
Liver function tests | Etiology tests | ||
ALT AST CPK GGT | Conjugated and unconjugated bilirubin Protein electrophoresis Serum albumin Prothrombin time and partial thromboplastin time Blood cell count Hepatic ultrasonography If only AST elevation is confirmed: PEG test and electrophoresis for macro-AST | Viral markers (HAV, HBV, HCV) Minor hepatotropic viruses serology (e.g., EBV, CMV) Ceruloplasmin, serum copper ANA, SMA, LKM, LC1, anti-SLA, total IgG Serum α1 antitrypsin EMA, tTgasi IgA, deamidated AGA IgA (< 2 yr), total IgA | Urinary copper, molecular ATP B7 analysis HCV RNA, HBV DNA Genetic and metabolic enlarged screening2 (“non-alcoholic fatty liver disease bin”) Sweat test Fecal elastase, steatocrit Other hepatic imaging techniques (MRI, ERCP, CT, etc.) Liver biopsy3 Jejunal biopsy (after celiac disease serology) |
- Citation: Vajro P, Maddaluno S, Veropalumbo C. Persistent hypertransaminasemia in asymptomatic children: A stepwise approach. World J Gastroenterol 2013; 19(18): 2740-2751
- URL: https://www.wjgnet.com/1007-9327/full/v19/i18/2740.htm
- DOI: https://dx.doi.org/10.3748/wjg.v19.i18.2740